ISTA PHARMACEUTICALS TO ISSUE $40 MILLION 8% SENIOR SUBORDINATED CONVERTIBLE NOTES

A A

ISTA Pharmaceuticals, Inc., announced today it has entered into a definitive agreement with several institutional investors to issue $40 million aggregate principal amount of senior subordinated convertible notes. The sale of the notes is expected to close on or before June 23, 2006, subject to customary closing conditions.

Drug Newswire (http://www.drugnewswire.com/2434/)